Human placenta and fetal membranes contain peptide YY 1-36 and peptide YY 3-36

Journal of Endocrinology

Volumn 156, Issue 3, 1998, Pages 485-492

  Xiao, Q ^a,b   Man, X ^c   Arany, E ^a   Hill, D ^a   Challis, J R G ^c   McDonald, T J ^a,b,d  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE YY;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHORION; CYTOTROPHOBLAST; DECIDUA; EPITHELIUM CELL; FETUS MEMBRANE; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROTRANSMITTER RELEASE; PLACENTA; PRIORITY JOURNAL; PROTEIN FAMILY; SYNCYTIOTROPHOBLAST;

AMNION; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DECIDUA; EXTRAEMBRYONIC MEMBRANES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; PEPTIDE YY; PLACENTA; PREGNANCY; RADIOIMMUNOASSAY; TROPHOBLASTS;

EID: 2642613636     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1560485     Document Type: Article

References (37)

1. Adrian TE, Smith HA, Calvert SA, Aynsley-Green A & Bloom SR 1986 Elevated plasma peptide YY in human neonates and infants. Pediatric Research 20 1225-1227.
2. Erlinge D, Brunkwall J & Edvinsson L 1994 Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATP. Regulatory Peptides 50 259-265.
3. Fraser M, Carter AM, Challis JRG & McDonald TJ 1992 Gastrin releasing peptide immunoreactivity is present in ovine amniotic fluid and fetal and maternal circulations. Endocrinology 131 2033-2035.
4. Fraser M, McDonald TJ, Spindel ER, Fahy M, Hill D & Challis JRG 1994 Gastrin releasing peptide is produced in the pregnant ovine uterus. Endocrinology 135 2440-2445.
5. Furness JB, Costa M, Emson PC, Håkanson R, Moghimzadeh E, Sundler F, Taylor IL & Chance RE 1983 Distribution pathways and reactions to drug treatment of nerves with neuropeptide Y- and pancreatic polypeptide-like immunoreactivity in the guinea-pig digestive tract. Cell and Tissue Research 234 71-92.
6. Gehlert DR, Beavers LS, Johnson D, Gackenheimer SL, Schober DA & Gadski RA 1996 Expression cloning of a human brain neuropeptide Y Y2 receptor. Molecular Pharmacology 49 224-228.
7. Gerald C, Walker MW, Vaysse PJ-J, He C, Branchek TA & Weinshank RL 1995 Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. Journal of Biological Chemistry 270 26758-26761.
8. Gomez G, Zhang T, Rajaraman S, Thakore KN, Yanaihara N, Townsend CM Jr, Thompson JC & Greeley GH 1995 Intestinal peptide YY: ontogeny of gene expression in rat bowel and trophic actions on rat and mouse bowel. American Journal of Physiology 268 G71-G81.
9. Grandt D, Teyssen S, Schimiczek M, Reeve JR Jr, Feth F, Rascher W, Hirche H, Singer MV, Layer P, Goebell H, Ho FJ & Eysselein VE 1992 Novel generation of hormone receptor specificity by amino terminal processing of peptide YY. Biochemical and Biophysical Research Communications 186 1299-1306.
10. Grandt D, Schimiczek M, Beglinger Ch, Layer P, Goebell H, Eysselein VE & Reeve JR Jr 1994 Two molecular forms ot peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY 1-36 and PYY 3-36. Regulatory Peptides 51 151-159.
11. Grandt D, Schimiczek M, Rascher W, Feth F, Shively J, Lee TD, Davis MT, Reeve JR Jr & Michel MC 1996 Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors. Regulatory Peptides 67 33-37.
12. Guan D, Rivard N, Morisset J & Greeley GH Jr 1993 Effects of peptide YY on the growth of the pancreas and intestine. Endocrinology 132 219-223.
13. Herzog H, Hort YJ, Ball HJ, Hayes G, Shine J & Selbie LA 1992 Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proceedings of the National Academy of Sciences of the USA 89 5794-5798.
14. Kimmel JR, Hayden LJ & Pollock HG 1975 Isolation and characterization of a new pancreatic polypeptide hormone. Journal of Biological Chemistry 250 9369-9376.
15. Krause J, Eva C, Seeburg PH & Sprengel R 1992 Neuropeptide subtype pharmacology of a recombinantly expressed neuropeptide receptor. Molecular Pharmacology 41 817-821.
16. Larhammar D, Blomquist AG, Yee F, Jazin E, Yoo H & Wahlestedt C 1992 Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. Journal of Biological Chemistry 267 10935-10938.
17. Liu CD, Balasubramaniam A, Saxton RE, Paiva M & McFadden DW 1995a Human pancreatic cancer growth is inhibited by peptide YY and BIM-43004-1. Journal of Surgical Research 58 707-712.
18. Liu CD, Slice LW, Balasubramaniam A, Walsh JH, Newton TR, Saxton RE & McFadden DW 1995b Y2 receptors decrease human pancreatic cancer growth and intracellular cyclic adenosine monophosphate levels. Surgery 118 229-236.
19. Lundberg JM, Tatemoto K, Terenius L, Hellstrom PM, Mutt V, Hölkfelt T & Hamberger B 1982a Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proceedings of the National Academy of Sciences of the USA 79 4471-4475.
20. Lundberg JM, Terenius L, Hökfelt T, Martling CR, Tatemoto K, Mutt V, Polak J, Bloom SR & Goldstein M 1982b Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiologica Scandinavica 116 447-480.
21. McDonald TJ, Wang YF, Mao YK, Broad RM, Cook MA & Daniel EE 1993 PYY: a neuropeptide in the canine enteric nervous system. Regulatory Peptides 44 33-48.
22. Mentlein R, Dahms P, Grandt D & Kruger R 1993 Proteolytic processing of neuropeptide Y and peptide YY by dipeptidyl peptidase IV. Regulatory Peptides 49 133-144.
23. Millar BC, Schluter K-D, Zhou X-J, McDermott BJ & Piper HM 1994 Neuropeptide Y stimulates hypertrophy of adult ventricular cardiomyocytes. American Journal of Physiology 266 C1271-C1277.
24. Petraglia F, Calza L, Giardino L, Sutton S, Marrama P, Rivier J, Genazzani AR & Vale W 1989 Identification of immunoreactive neuropeptide-Y in human placenta: localization, secretion, and binding sites. Endocrinology 124 2016-2022.
25. Petraglia F, Calza L, Giardino L, Zanni M, Florio P, Ferrari AR, Nappi C & Genazzani AR 1993 Maternal decidua and fetal membranes contain immunoreactive neuropeptide Y. Journal of Endocrinological Investigation 16 201-205.
26. Rose PM, Fernandas P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, Kienzie B & Seethala R 1995 Cloning and expression of a cDNA encoding a human type 2 neuropeptide Y receptor. Journal of Biological Chemistry 270 22661-22664.
27. Sangha RK, Walton JC, Ensor CM, Tai H-H & Challis JRG 1994 Immunohistochemical localization, messenger ribonucleic acid abundance, and activity ot 15-hydroxy-prostaglandin dehydrogenase in placenta and fetal membranes during term and preterm labour. Journal of Clinical Endocrinology and Metabolism 78 982-989.
28. Schwartz TW 1983 Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 85 1411-1425.
29. Tatemoto K 1982a Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proceedings of the National Academy of Sciences of the USA 79 2514-2518.
30. Tatemoto K 1982b Neuropeptide Y: complete amino acid sequence of the brain peptide. Proceedings of the National Academy of Sciences of the USA 79 5485-5489.
31. Taylor IL 1989 The ileo-colonic, gastric and pancreatic inhibitor. Biological Bulletin 177 187-191.
32. Taylor IL, Impicciatore M, Carter DC & Walsh JH 1978 Effect of atropine and vagotomy on pancreatic polypeptide response to a mixed meal in dogs. American Journal of Physiology 235 E443-E447.
33. Wang YF, Mao YK, Xiao Q, Daniel EE, Borkowski KR & McDonald TJ 1997 The distribution of NPY-containing nerves and the catecholamine contents of canine enteric nerve plexuses. Peptides 18 221-234.
34. Wharton J, Gordon L, Byrne J, Herzog H, Selbie LA, Moore K, Sullivan MHF, Elder MG, Moscoso G, Taylor KM, Shine J & Polak JM 1993 Expression of the human neuropeptide tyrosine receptor. Proceedings of the National Academy of Sciences of the USA 90 687-691.
35. Xiao Q, Challis JRG, Fraser M, Wlodek ME, Thorburn GD, Cuttita F, Hill DJ, St-Pierre S, Spindel ER & McDonald TJ 1996a Locations and molecular forms of gastrin releasing peptide-like immunoreactive entities in ovine pregnancy. Peptides 17 489-495.
36. Xiao Q, Han X, Challis JRG, Hill DJ, Spindel ER, Prasad CJ, Akagi K & McDonald TJ 1996b Gastrin releasing peptide-like immunoreactivity is present in human maternal and fetal placental membranes. Journal of Clinical Endocrinology and Metabolism 81 3766-3773.
37. Zukowska-Grojec Z, Pruszczyk P, Colton C, Yao J, Shen GH, Myers AK & Wahlestedt C 1993 Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides 14 263-268.